PAVmed Inc expected to post a loss of 13 cents a share - Earnings Preview

PAVmed

12/05/2025 21:33

PAVmed Inc PAVM.OQ PAVM.O is expected to show a fall in quarterly revenue when it reports  results on May 14 for the period ending March 31 2025

The New York City-based  company is expected to report a 99.0% decrease in revenue to $10 thousand from $1.01 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for PAVmed Inc is for a loss of 13 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for PAVmed Inc is $11.75​, above​ its last closing price of $0.68. ​​​

This summary was machine generated May 12 at 20:33 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)